Utilization of biomarkers for the prognostic prediction of cardiac arrest survivors using a multi-modal approach  

作　　者：Changshin Kang Yeonho You Jung Soo Park Byeong Kwon Park Jae Kwang Lee Byung Kook Lee 

机构地区：[1]Department of Emergency Medicine,College of Medicine,Chungnam National University,Daejeon 35015,Republic of Korea [2]Department of Emergency Medicine,Chungnam National University Hospital,Daejoen 35015,Republic of Korea [3]Department of Emergency Medicine,Konyang University Hospital,College of Medicine,Daejeon 35015,Republic of Korea [4]Department of Emergency Medicine,Chonnam National University Medical School,Chonnam National University Hospital,Gwangju 61469,Republic of Korea

出　　处：《World Journal of Emergency Medicine》2024年第2期131-134,共4页世界急诊医学杂志（英文）

基　　金：supported by the research fund of Chungnam National University in 2022。

摘　　要：International guidelines for post-cardiac arrest care recommend using multi-modal strategies to avoid the withdrawal of life-sustaining therapy(WLST)in patients with the potential for neurological recovery.[1]However,a clear methodology for multi-modal approaches has yet to be developed.Neuron-specific enolase(NSE)is currently the only recommended biomarker,and the European Resuscitation Council(ERC)and the European SocietyofIntensiveCareMedicine(ESICM)have proposed a cutoff value of 60μg/L at 48 and/or 72 h after the return of spontaneous circulation(ROSC)as a multimodal prognostic tool for predicting poor neurological outcomes.

关 键 词：CARDIAC MODAL RETURN 

分 类 号：R541.78[医药卫生—心血管疾病]